Pharmafile Logo
Pharmafocus logo
Advanced Search

Actavis

Showing 15 posts of 53 posts found.

gavel

Patently problematic? The impact of the Eli Lilly/Actavis intellectual property battle

September 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Eli Lilly, biotech, drugs, pemetrexed, pharma, pharmaceutical

The UK Supreme Court has sent shockwaves through the intellectual property world with its recent decision on Eli Lilly v …

Feature
gilead-sciences

Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland

July 6, 2017
Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada

Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …

News
money-256281_960_720

Five most talked about mergers and acquisitions of 2016

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Bayer, Boehringer, Johnson & Johnson, Sanofi, Teva, acquisition, mergers, monsanto, pharma

2017 has kicked off with a bang – as Johnson & Johnson confirmed a $30 billion deal to takeover of …

Feature

Actavis UK overcharged NHS with 12,000% price hike, watchdog says

December 16, 2016
Medical Communications, Sales and Marketing Actavis, CMA, NHS

Actavis UK has been accused by the Competition and Markets Authority (CMA) of overcharging the NHS by selling its hydrocortisone …

News
1024px-lyrica

Pfizer loses UK patent infringement case over $5.1bn drug

October 13, 2016
Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, patent infringement, pregabalin

Pfizer has been dealt a significant blow as the UK Court of Appeal has rejected the company’s patent infringement claims …

News
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

August 5, 2016
Medical Communications, Research and Development Actavis, Bioelectronics, CDF, Celgne, EMA, GSK, GlaxoSmithKline, Innovate UK, Medivation, NICE, Novartis, Roche, Sanofi, Teva, appointments, apremilast, biog, breast cancer, brexit, google, pharmaceutical industry, rheumatoid arthritis, sarilumab, top ten

It’s Friday, and we’ve seen some big developments in the industry’s headlines throughout the week, from news of Glaxo-Smith-Kilne’s new …

News
teva_copy

Teva completes $40 billion acquisition of Actavis Generics

August 3, 2016
Research and Development, Sales and Marketing Actavis, Allergan, Teva, acqusition, generics

Teva has announced that it has completed its acquisition of Actavis Generics, a subsidiary of Allergan, in a transaction valued …

News
lilly_entrance_web

German Supreme Court grants Lilly appeal to block Alimta generics

June 15, 2016
Research and Development, Sales and Marketing Actavis, Alimta, Eli Lilly

Eli Lilly (NYSE: LLY) has announced that it has been granted an appeal by the German Federal Supreme Court, in …

News
eli_lilly

Lilly suffers damaging Alimta patent blow

February 15, 2016
Manufacturing and Production, Sales and Marketing Actavis, Alimta, Allergan, Eli Lilly, pemetrexed

Eli Lilly says it plans to appeal a UK High Court’s verdict that could imminently open its blockbuster lung cancer …

News
abpi_code_of_practice_2011

Bayer takes on Actavis in ABPI code conduct breach

November 26, 2015
Medical Communications, Sales and Marketing ABPI, Actavis, Bayer, PMCPA

The Prescription Medicines Code of Practice Authority (PMCPA) has ruled in favour of Bayer in a case brought against Actavis. …

News
allergan_pfizer_logos

Pfizer in ‘friendly’ merger talks with Allergan

October 29, 2015
Sales and Marketing Actavis, Allergan, Pfizer, Teva

Pfizer is in talks with Allergan over what could be the largest takeover deal in an already record-breaking year, it …

News
lyrica

High Court rules against Pfizer in Lyrica patent case

September 10, 2015
Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin

The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …

News
Takeda oncology

Takeda in Velcade patent blow

August 25, 2015
Manufacturing and Production Actavis, Sandoz, Takeda, Velcade, bortezomib, ixazomib

Takeda has lost a court case contesting the patent for its blockbuster multiple myeloma drug Velcade, in a decision that …

News
Actavis facility in Iceland

Allergan closing manufacturing facility in Iceland

July 14, 2015
Manufacturing and Production Actavis, Allergan, Iceland, manufacturing, production, redundancies

Actavis is shutting a plant in Iceland, where its recently-acquired company Actavis has roots, and cutting 300 jobs in the …

News
package_of_lutera_birth_control_pills

Actavis contraceptives recalled after packaging errors

July 9, 2015
Manufacturing and Production Actavis, FDA, manufacturing, packaging, product recall, production, recalls

Actavis is voluntarily recalling more than half a million boxes of contraceptive pills in the United States due to problems …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023